Disparities in Prostate Cancer
Prostate cancer is the most commonly diagnosed non-skin cancer in the US and the second most common cause of cancer death among American men. In 2008 an estimated 186,320 men will be diagnosed with, and 28,660 will die of, prostate cancer in the US. Incidence rates increased dramatically in the 1990s attributable to prostate cancer screening but then declined after uncovering of prevalent cases. Mortality rates have trended downward in the past 15 years (Fig. 8.1).
KeywordsProstate Cancer Radical Prostatectomy Prostate Cancer Risk Prostate Cancer Screening Sickle Cell Trait
- Akaza, H., Miyanaga, N., Takashima, N., Naito, S., Hirao, Y., Tsukamoto, T. et al. Comparisons of percent equal producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean, and American residents. Jap J Clin Oncol. 2004; 34(2):86–89.CrossRefGoogle Scholar
- American Cancer Society (2009). Chief medical officer Otis W. Brawley responds to prostate cancer studies. American Cancer Society. Retrieved March 25, 2008, from http://www.cancer.org/docroot/MED/content/MED_2_1×_Chief_Medical_Officer_Otis_W_Brawley_Responds_to_Prostate_Studies.asp.
- Andriole, G.L., Grubb, R.L., III, Buys, S.S., Chia, D., Church, T.R., Fouad, M.N., et al. Mortality results from a radomized prostate-cancer screening trial. New Engl J Med. 2009; 360(13). Retrieved March 26, 2009, from http://content.nejm.org/cgi/content/full/NEJMoa0810696.
- Barry, M.J. Screening for prostate cancer – The controversy that refuses to die. New Engl J Med. 2009; 360(13). Retrieved March 26, 2009, from http://content.nejm.org/cgi/content/full/NEJMe0901166.
- Brewster, D.H., Thomson, C.S., Hole, D.J., Black, R.J., Stroner, P.L., Gillis, C.R. Relation between socioeconomic status and tumor stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies. BMJ. 2001; 322(7290):830–831.PubMedCrossRefGoogle Scholar
- de Koning, H.J., Auvinen, A., Berenguer-Sanchez, A., Calais da Silva, F, Ciatto, S., Denis, L. et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary Cancer trial. Int J Cancer. 2002; 97(2):237–244.PubMedCrossRefGoogle Scholar
- Du, X.L., Fang, S., Coker, A.L., Sanderson, M., Aragaki, C., Cormier, J.N. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006; 106(6):1276–1285.PubMedCrossRefGoogle Scholar
- Giovannucci, E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epid. 2009; 19(2):87–88.Google Scholar
- Godley, P.A., Schenck, A.P., Amamoo, M.A., Schoenbach, V.J., Peacock, S., Manning, M. et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003; 95(22):1702–1710.Google Scholar
- Gordon, N.H. Association of education and income with estrogen receptor status in primary breast cancer. Am J Epid. 1995; 142(8):796–803.Google Scholar
- Greenlee, R.T., Murray, T., Bolden, S., Wing, P.A., Cancer Statistics, 50: 7–33, 2000.Google Scholar
- Johnstone, P.A., Kane, C.J., Sun, L., Wu, H., Moul, J.W., McLeod, D.G. et al. Effect of race on biochemical disease-free outcome in patients with prostate cancer treated with definitive radiation therapy in an equal-access health care system: radiation oncology report of the Department of Defense Center for Prostate Disease Research. Radiology. 2002; 225(2):420–426.PubMedCrossRefGoogle Scholar
- Kumar, R.J., Baha Barqawi, A.B., Crawford, E.D. Epidemiology of prostate cancer. Business Briefing: US Oncology Review 2004: 42–45.Google Scholar
- Lu-Yao, G., Albertsen, P.C., Stanford, J.L., Stukel, T.A., Walker-Corkery, E.S., Barry, M.J. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ. 2002; 325(7367):740.PubMedCrossRefGoogle Scholar
- McLeod, D.G., Schellhammer, P.F., Vogelzang, N.J., Soloway, M.S., Sharifi, R., Black, N.L. et al. Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group. Prostate. 1999; 40(4):218–224.PubMedCrossRefGoogle Scholar
- Odedina, F.T., Ogunbiyi, J.O., Ukoli, F.A. Roots of prostate cancer in African-American men. J Natl Med Assn. 2006; 98(4):539–543.Google Scholar
- Pan, C.C., Lee, J.S., Chan, J.L., Sandler, H.M., Underwood, W., McLaughlin, P.W. The association between presentation PSA and race in two sequential time periods in prostate cancer patients seen at a university hospital and its community affiliates. Int J Rad Oncology, Biology, Physics. 2003; 57(5):1292–1296.CrossRefGoogle Scholar
- Park, J., Chen, L., Ratnashinge, L., Sellers, T.A., Tanner, J.P., Lee, J.H. et al. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer, Epidemiology, Biomarkers, and Prevention. 2006; 15(8):1473–1478.CrossRefGoogle Scholar
- Parkin, D.M., Whelan, S.L., Ferlay, J., Raymond, L., Young, J., eds. Cancer Incidence in Five Continents, Vol 7. Lyon (France), IARC Scientific Publication No. 143, IARC Press; 1997.Google Scholar
- Potosky, A.L., Feuer, E.J., Levin, D.L. Impact of screening on incidence and mortality in the United States. Epidem Rev. 2001; 23(1):181–186.Google Scholar
- Ries L.A.G., Melbert, D., Krapcho, M., Stinchcomb, D.G., Howlader, N., Horner, M.J., Mariotto, A., Miller, B.A., Feuer, E.J., Altekruse, S.F., Lewis, D.R., Clegg, L., Eisner, M.P., Reichman, M., Edwards, B.K., (Eds). SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2005, based on November 2007 SEER data submission, posted to the SEER web site, 2008.
- Ries, L.A.G., Harkins, D., Krapcho, M., Mariotto, A., Miller, B.A., Feuer, E.J. et al. SEER cancer statistic review, 1975–2003. Bethesda: National Cancer Institute, 2006 http://www.seercancer.gov/csr/1975–2002. Accessed August 4, 2008.
- Roach, M., III. Krall, J., Keller, J.W., Perez, C.A., Sause, W.T., Doggett, R.L. et al. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976–1985). Int J Rad Oncol Biol Phys. 1992; 24(3):441–449.CrossRefGoogle Scholar
- Robbins, A.S., Whittemore, A.S., Thom, D.H. Differences in socioeconomic status and survival among white and black men with prostate cancer. Am J Epidem. 2000; 151(4):409–416.Google Scholar
- Schro¨der, F.H., Hugosson, J., Roobol, M.J., Tammela, T.L.J., Ciatto, S., Nelen, V., et al. Screening and prostate-cancer mortality in a randomized European study. New Engl J Med. 2009; 360(13). Retrieved March 26, 2009, from http://content.nejm.org/cgi/content/full/NEJMoa0810084.
- Shavers, V.L., Brown, M.L. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 94(5):334–357.Google Scholar
- Shekarriz, B., Tiguert, R., Upadhyay, J., Gheiler, E., Powell, I.J., Pontes, J.E. et al. Impact of location and multifocality of positive surgical margins on disease-free survival following radical prostatectomy: a comparison between African-American and white men. Urol. 2000; 55(6):899–903.PubMedCrossRefGoogle Scholar
- U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Task Force Recommendation Statement. Ann Int Med. 2008; 149 (3):185–191.Google Scholar
- Williams, D.R. The health of U.S. racial and ethnic populations. Journal of Gerontology. Series B. Psych Sci Soc Scie. 2005; 60(2):53–62.Google Scholar
- Wood, H.M., Reuther, A.M., Gilligan, T.D., Kupelian, P.A., Modlin, C.S., Jr., Klein, E.A. Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration. Journal of Urology. 2007; 178(4 Pt 1):1271–1276.PubMedCrossRefGoogle Scholar